Fig. 2: Isolated micro-tumours recapitulate patient tumour material. | npj Precision Oncology

Fig. 2: Isolated micro-tumours recapitulate patient tumour material.

From: Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer

Fig. 2

A Ovarian cancer marker expression in original tumour material determined in the clinic (left, n = 34) and isolated micro-tumours (right, n = 43). Percentage of samples positive for each marker is indicated on the top. B Representative images of patient and micro-tumour pathological stainings. C Tumour marker positivity comparing original tumour material to isolated micro-tumours. Numbers indicate the number of samples per combination of original/micro-tumour score. D PAX8 positivity score at the start and end point of the ex vivo drug sensitivity assay. Percentage of samples positive is indicated on the top.

Back to article page